Advertisement

Adverse Events

Removing Bias from HEOR: Standardizing the Costs of Adverse Events

April Rieger2023-12-14T13:11:12-05:00June 15th, 2015|Categories: Blog, HEOR Feature|Tags: Adverse Events, budget impact models, Cost Effectiveness Analysis, costings, Costs, Health Economic Models, Health Economics and Outcomes Research, health outcomes models, HEOR, payers, real world evidence, tHEORetically Speaking|

By Jim Davis What are the total costs of prescribing a particular drug? At its core, all health [...]

21st Century Cures and Off-Label Promotion Benefit HEOR and Drug Safety

April Rieger2023-12-14T13:11:13-05:00June 4th, 2015|Categories: Blog, HEOR Feature|Tags: Adverse Events, FDA, FDAMA 114, Health Economic Models, Health informatics, real world evidence, tHEORetically Speaking, transparency|

By Jim Davis As my writing for the AdverseEvents Blog can attest, I’m in favor of data transparency. [...]